Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: retrospective single-center 476 COVID-19 patients; CACOVID-CT quantifies affected lung area and CT severity score, correlated with length of stay, ICU admission, ventilation and death. Internal observational evidence only.
Technology: AI quantification is tied to patient outcomes in a defined clinical study; no causal or clinical-impact claim.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- AI quantification is tied to patient outcomes in a defined clinical study; no causal or clinical-impact claim.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.930055/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.